VAC 02
Alternative Names: VAC-02Latest Information Update: 29 Apr 2021
At a glance
- Originator Minka Therapeutics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 30 Mar 2021 Preclinical trials in HIV infections (Prevention) in France (unspecified route) (Minka Therapeutics pipeline, March 2021)